266329
Antimony
powder, -100 mesh, 99.5% trace metals basis
Synonym(s):
Antimony black, Antimony element
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
Sb
CAS Number:
Molecular Weight:
121.76
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141704
EC Number:
231-146-5
MDL number:
assay
99.5% trace metals basis
form
powder
composition
Sb
reaction suitability
core: antimony
resistance
41.7 μΩ-cm
particle size
-100 mesh
bp
1635 °C (lit.)
density
6.69 g/mL at 25 °C (lit.)
SMILES string
[Sb]
InChI
1S/Sb
InChI key
WATWJIUSRGPENY-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Antimony
signalword
Warning
hcodes
Hazard Classifications
Carc. 2 - STOT RE 2 Inhalation
target_organs
Lungs
Storage Class
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Daoyong Zhang et al.
Bioresource technology, 128, 711-715 (2012-12-19)
Extracellular polymeric substances (EPS) existed ubiquitously in biological systems affect the mobility and availability of heavy metals in the environments. The adsorption-desorption behaviors of Hg(II) and Sb(V) on EPS were investigated. The sorption rates follow Sb(V) > Hg(II), and the
Budhaditya Mukherjee et al.
Proceedings of the National Academy of Sciences of the United States of America, 110(7), E575-E582 (2013-01-24)
The molecular mechanism of antimony-resistant Leishmania donovani (Sb(R)LD)-driven up-regulation of IL-10 and multidrug-resistant protein 1 (MDR1) in infected macrophages (Ms) has been investigated. This study showed that both promastigote and amastigote forms of Sb(R)LD, but not the antimony-sensitive form of
Joseph N Jarvis et al.
Current opinion in infectious diseases, 26(1), 1-9 (2012-12-12)
HIV infection profoundly impairs the immune mechanisms needed to control and clear Leishmania infection, and outcomes in patients with HIV-associated visceral leishmaniasis are poor. This review summarizes recent work describing the epidemiology, presentation and outcomes of HIV-associated visceral leishmaniasis and
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 266329-1KG | 04061826133842 |
| 266329-250G | 04061826133859 |